Autologous and Allogenic Utilization of Stromal Vascular Fraction and Decellularized Extracellular Matrices in Orthopedic Surgery: A Scoping Review
- PMID: 36452418
- PMCID: PMC9702025
- DOI: 10.22038/ABJS.2022.59635.2943
Autologous and Allogenic Utilization of Stromal Vascular Fraction and Decellularized Extracellular Matrices in Orthopedic Surgery: A Scoping Review
Abstract
Background: This narrative review of the literature aims to analyze the utilization of stromal vascular fraction (SVF) and decellularized extracellular matrices (dECMs) in various pathologies related to orthopedic surgery.
Methods: A literature search was carried out in PubMed on February 15, 2022, using "Stroma Vascular Fraction and Orthopedic Surgery" and "Decellularized Extracellular Matrices and Orthopedic Surgery" as keywords. A total of 278 articles were found, of which 28 papers were selected because they seemed to be the most appropriate concerning the title of the article.
Results: The reported results have shown that intra-articular injection of SVF seems to be a safe and efficacious method for managing knee osteoarthritis (OA). Platelet-rich plasma (PRP) and SVF are safe and effective management for intractable Achilles tendinopathy in humans, although subjects treated with SVF recover earlier. There are promising results in utilizing adipose-derived mesenchymal stromal cells in chronic lateral epicondylitis of the elbow in athletes. Ready-to-use ECM/SVF gel seems to be a good therapeutic option promoting the regeneration of the articular cartilage in subjects with injuries of the cartilage. The SVF can safely be used to treat diabetic subjects suffering from chronic foot ulcers.
Conclusion: There are scarce high-quality data for utilizing cell-based approach in soft tissue injuries of the knee in athletes. Experimental studies indicate that SVF could be a new option to osseous regeneration. Other experimental studies support the utilization of dECMs as a scaffold for the regeneration of large osseous defects, cell-derived dECMs scaffolds to repair articular cartilage injuries, and utilization of xenogeneic acellular muscles to manage volumetric muscle loss where there is a lack of donor site.Intra-articular injections of SVF seems to be a safe and efficacious method for managing OA of the knee joint. Platelet-rich plasma (PRP) and SVF are safe and efficacious methods for the management of intractable Achilles tendinopathy in humans, although subjects treated with SVF recover earlier.
Keywords: Bone regeneration; Cartilage regeneration; Decellularized extracellular matrices; Osteoarthritis; Stromal vascular fraction; Tendon healing.
Figures



Similar articles
-
Systematic Review: Allogenic Use of Stromal Vascular Fraction (SVF) and Decellularized Extracellular Matrices (ECM) as Advanced Therapy Medicinal Products (ATMP) in Tissue Regeneration.Int J Mol Sci. 2020 Jul 15;21(14):4982. doi: 10.3390/ijms21144982. Int J Mol Sci. 2020. PMID: 32679697 Free PMC article.
-
Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up.Knee Surg Sports Traumatol Arthrosc. 2018 Jul;26(7):2000-2010. doi: 10.1007/s00167-017-4479-9. Epub 2017 Mar 1. Knee Surg Sports Traumatol Arthrosc. 2018. PMID: 28251260 Clinical Trial.
-
Autologous Adipose-Derived Tissue Stromal Vascular Fraction (AD-tSVF) for Knee Osteoarthritis.Int J Mol Sci. 2022 Nov 4;23(21):13517. doi: 10.3390/ijms232113517. Int J Mol Sci. 2022. PMID: 36362308 Free PMC article. Review.
-
Comparison of Platelet-Rich Plasma, Stromal Vascular Fraction (SVF), or SVF with an Injectable PLGA Nanofiber Scaffold for the Treatment of Osteochondral Injury in Dogs.J Knee Surg. 2018 Aug;31(7):686-697. doi: 10.1055/s-0037-1606575. Epub 2017 Sep 15. J Knee Surg. 2018. PMID: 28915522
-
Assessment of safety and efficacy of intra-articular injection of stromal vascular fraction for the treatment of knee osteoarthritis-a systematic review.Int Orthop. 2021 Mar;45(3):615-625. doi: 10.1007/s00264-020-04926-x. Epub 2021 Jan 12. Int Orthop. 2021. PMID: 33432400
Cited by
-
Analyzing the Clinical Potential of Stromal Vascular Fraction: A Comprehensive Literature Review.Medicina (Kaunas). 2024 Jan 27;60(2):221. doi: 10.3390/medicina60020221. Medicina (Kaunas). 2024. PMID: 38399509 Free PMC article.
-
Comparison of short-term clinical outcomes of intra-articular injection of micro-fragmented adipose tissue and stromal vascular fraction cells for knee osteoarthritis treatment: A retrospective single-center cohort study.Regen Ther. 2025 Mar 12;29:91-99. doi: 10.1016/j.reth.2025.02.013. eCollection 2025 Jun. Regen Ther. 2025. PMID: 40129683 Free PMC article. Review.
-
Stromal Vascular Fraction Therapy for Knee Osteoarthritis: A Systematic Review.Medicina (Kaunas). 2023 Nov 28;59(12):2090. doi: 10.3390/medicina59122090. Medicina (Kaunas). 2023. PMID: 38138193 Free PMC article.
-
Stromal vascular fraction in canine osteoarthritis: advantages, applications, and insights for veterinary practitioners.Front Vet Sci. 2025 May 16;12:1586629. doi: 10.3389/fvets.2025.1586629. eCollection 2025. Front Vet Sci. 2025. PMID: 40454169 Free PMC article. Review.
References
-
- Van Schaik KD, Kenneth SL. Orthobiologics: diagnosis and treatment of common tendinopathies. Semin Musculoskelet Radiol. 2021;25(6):735–44. - PubMed
-
- Gentile P, Sterodimas A, Pizzicannella J, Dionisi L, De Fazio D, Calabrese C, et al. Systematic Review: allogenic use of stromal vascular fraction (SVF) and decellularized extracellular matrices (ECM) as advanced therapy medicinal products (ATMP) in tissue regeneration. Int J Mol Sci. 2020;21(14):4982. - PMC - PubMed
-
- Blaudez F, Ivanovski S, Hamlet S, Vaquette C. An overview of decellularisation techniques of native tissues and tissue engineered products for bone, ligament and tendon regeneration. Methods. 2020:171:28–40. - PubMed
-
- Mehranfar S, Abdi Rad I, Mostafav E, Akbarzadeh A. The use of stromal vascular fraction (SVF), platelet-rich plasma (PRP) and stem cells in the treatment of osteoarthritis: an overview of clinical trials. Artif Cells Nanomed Biotechnol. 2019;47(1):882–90. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials